Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to assess the efficacy of intranasal esketamine plus an oral antidepressant compared with an oral antidepressant (active comparator) plus intranasal placebo in delaying relapse of depressive symptoms in subjects with TRD who are in stable remission after an induction and optimization course of intranasal esketamine plus an oral antidepressant.
Critère d'inclusion
- Treatment-resistant Major Depression